Literature DB >> 20592470

Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy.

Koichi Ojima1, Yukiko Kawabata, Harumi Nakao, Kazuki Nakao, Naoko Doi, Fujiko Kitamura, Yasuko Ono, Shoji Hata, Hidenori Suzuki, Hiroyuki Kawahara, Julius Bogomolovas, Christian Witt, Coen Ottenheijm, Siegfried Labeit, Henk Granzier, Noriko Toyama-Sorimachi, Michiko Sorimachi, Koichi Suzuki, Tatsuya Maeda, Keiko Abe, Atsu Aiba, Hiroyuki Sorimachi.   

Abstract

Limb-girdle muscular dystrophy type 2A (LGMD2A) is a genetic disease that is caused by mutations in the calpain 3 gene (CAPN3), which encodes the skeletal muscle-specific calpain, calpain 3 (also known as p94). However, the precise mechanism by which p94 functions in the pathogenesis of this disease remains unclear. Here, using p94 knockin mice (termed herein p94KI mice) in which endogenous p94 was replaced with a proteolytically inactive but structurally intact p94:C129S mutant protein, we have demonstrated that stretch-dependent p94 distribution in sarcomeres plays a crucial role in the pathogenesis of LGMD2A. The p94KI mice developed a progressive muscular dystrophy, which was exacerbated by exercise. The exercise-induced muscle degeneration in p94KI mice was associated with an inefficient redistribution of p94:C129S in stretched sarcomeres. Furthermore, the p94KI mice showed impaired adaptation to physical stress, which was accompanied by compromised upregulation of muscle ankyrin-repeat protein-2 and hsp upon exercise. These findings indicate that the stretch-induced dynamic redistribution of p94 is dependent on its protease activity and essential to protect muscle from degeneration, particularly under conditions of physical stress. Furthermore, our data provide direct evidence that loss of p94 protease activity can result in LGMD2A and molecular insight into how this could occur.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592470      PMCID: PMC2912184          DOI: 10.1172/JCI40658

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules.

Authors:  Melanie K Miller; Marie-Louise Bang; Christian C Witt; Dietmar Labeit; Charles Trombitas; Kaori Watanabe; Henk Granzier; Abigail S McElhinny; Carol C Gregorio; Siegfried Labeit
Journal:  J Mol Biol       Date:  2003-11-07       Impact factor: 5.469

2.  The protease core of the muscle-specific calpain, p94, undergoes Ca2+-dependent intramolecular autolysis.

Authors:  Michelle A Rey; Peter L Davies
Journal:  FEBS Lett       Date:  2002-12-18       Impact factor: 4.124

Review 3.  Calpain 3: a key regulator of the sarcomere?

Authors:  Stéphanie Duguez; Marc Bartoli; Isabelle Richard
Journal:  FEBS J       Date:  2006-08       Impact factor: 5.542

Review 4.  Calpains and muscular dystrophies.

Authors:  J G Tidball; M J Spencer
Journal:  Int J Biochem Cell Biol       Date:  2000-01       Impact factor: 5.085

5.  Eccentric exercise-induced morphological changes in the membrane systems involved in excitation-contraction coupling in rat skeletal muscle.

Authors:  H Takekura; N Fujinami; T Nishizawa; H Ogasawara; N Kasuga
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

Review 6.  The calpain system.

Authors:  Darrell E Goll; ValeryY F Thompson; Hongqi Li; Wei Wei; Jinyang Cong
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

7.  Induction and myofibrillar targeting of CARP, and suppression of the Nkx2.5 pathway in the MDM mouse with impaired titin-based signaling.

Authors:  Christian C Witt; Yasuko Ono; Eva Puschmann; Mark McNabb; Yiming Wu; Michael Gotthardt; Stephanie H Witt; Markus Haak; Dietmar Labeit; Carol C Gregorio; Hiroyuki Sorimachi; Henk Granzier; Siegfried Labeit
Journal:  J Mol Biol       Date:  2004-02-06       Impact factor: 5.469

8.  Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle.

Authors:  Yoko Keira; Satoru Noguchi; Narihiro Minami; Yukiko K Hayashi; Ichizo Nishino
Journal:  J Biochem       Date:  2003-05       Impact factor: 3.387

9.  Characterization of human skeletal muscle Ankrd2.

Authors:  A Pallavicini; S Kojić; C Bean; M Vainzof; M Salamon; C Ievolella; G Bortoletto; B Pacchioni; M Zatz; G Lanfranchi; G Faulkner; G Valle
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

10.  Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.

Authors:  I Richard; C Roudaut; S Marchand; S Baghdiguian; M Herasse; D Stockholm; Y Ono; L Suel; N Bourg; H Sorimachi; G Lefranc; M Fardeau; A Sébille; J S Beckmann
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

View more
  47 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Contractile function and sarcolemmal permeability after acute low-load resistance exercise with blood flow restriction.

Authors:  Mathias Wernbom; Gøran Paulsen; Tormod S Nilsen; Jonny Hisdal; Truls Raastad
Journal:  Eur J Appl Physiol       Date:  2011-09-27       Impact factor: 3.078

3.  Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Venkateswaran Subramanian; Haruhito A Uchida; Talha Ijaz; Jessica J Moorleghen; Deborah A Howatt; Anju Balakrishnan
Journal:  J Cardiovasc Pharmacol       Date:  2012-01       Impact factor: 3.105

4.  PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1.

Authors:  Yasuko Ono; Shun-Ichiro Iemura; Stefanie M Novak; Naoko Doi; Fujiko Kitamura; Tohru Natsume; Carol C Gregorio; Hiroyuki Sorimachi
Journal:  J Mol Biol       Date:  2013-05-21       Impact factor: 5.469

5.  Characterization of muscle ankyrin repeat proteins in human skeletal muscle.

Authors:  Stefan G Wette; Heather K Smith; Graham D Lamb; Robyn M Murphy
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-14       Impact factor: 4.249

Review 6.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

7.  Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A.

Authors:  William Lostal; Carinne Roudaut; Marine Faivre; Karine Charton; Laurence Suel; Nathalie Bourg; Heather Best; John Edward Smith; Jochen Gohlke; Guillaume Corre; Xidan Li; Zaher Elbeck; Ralph Knöll; Jack-Yves Deschamps; Henk Granzier; Isabelle Richard
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

8.  C3KO mouse expression analysis: downregulation of the muscular dystrophy Ky protein and alterations in muscle aging.

Authors:  Oihane Jaka; Irina Kramerova; Margarita Azpitarte; Adolfo López de Munain; Melissa Spencer; Amets Sáenz
Journal:  Neurogenetics       Date:  2012-07-22       Impact factor: 2.660

Review 9.  Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Cell Mol Life Sci       Date:  2017-04-21       Impact factor: 9.261

10.  Three calpain isoforms are autolyzed in rat fast-twitch muscle after eccentric contractions.

Authors:  Keita Kanzaki; Mai Kuratani; Satoshi Matsunaga; Noriyuki Yanaka; Masanobu Wada
Journal:  J Muscle Res Cell Motil       Date:  2014-02-21       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.